Adaptive Biotechnologies Corporation (NASDAQ: ADPT) kicked off on May 23, 2023, at the price of $6.34, up 2.67% from the previous trading day. During the day, the shares moved up to $6.68 and dropped to $6.34 before settling in for the closing price of $6.37. Over the past 52 weeks, ADPT has traded in a range of $5.95-$13.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 37.00% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 4.90%. With a float of $140.66 million, this company’s outstanding shares have now reached $143.51 million.
In an organization with 790 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +57.46, operating margin of -106.94, and the pretax margin is -108.13.
Adaptive Biotechnologies Corporation (ADPT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corporation is 0.20%, while institutional ownership is 89.30%. The most recent insider transaction that took place on Apr 11, was worth 19,918. In this transaction Chief Operating Officer of this company sold 2,308 shares at a rate of $8.63, taking the stock ownership to the 175,361 shares. Before that another transaction happened on Apr 10, when Company’s Chief Operating Officer sold 817 for $8.50, making the entire transaction worth $6,944. This insider now owns 177,669 shares in total.
Adaptive Biotechnologies Corporation (ADPT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 3/30/2023, the organization reported -$0.4 earnings per share (EPS), lower than consensus estimate (set at -$0.38) by -$0.02. This company achieved a net margin of -108.03 while generating a return on equity of -37.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.60% during the next five years compared to -31.30% drop over the previous five years of trading.
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Trading Performance Indicators
Take a look at Adaptive Biotechnologies Corporation’s (ADPT) current performance indicators. Last quarter, stock had a quick ratio of 5.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.36, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.01 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corporation (ADPT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.96 million. That was better than the volume of 0.93 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 35.74%. Additionally, its Average True Range was 0.47.
During the past 100 days, Adaptive Biotechnologies Corporation’s (ADPT) raw stochastic average was set at 12.01%, which indicates a significant decrease from 42.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.24% in the past 14 days, which was higher than the 69.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.68, while its 200-day Moving Average is $8.34. However, in the short run, Adaptive Biotechnologies Corporation’s stock first resistance to watch stands at $6.70. Second resistance stands at $6.86. The third major resistance level sits at $7.04. If the price goes on to break the first support level at $6.36, it is likely to go to the next support level at $6.18. Assuming the price breaks the second support level, the third support level stands at $6.02.
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Key Stats
The company with the Market Capitalisation of 930.31 million has total of 144,311K Shares Outstanding. Its annual sales at the moment are 185,310 K in contrast with the sum of -200,190 K annual income. Company’s last quarter sales were recorded 37,650 K and last quarter income was -57,700 K.
